Germplasm Bank
The Germplasm Bank is committed to providing healthy and viable seed, as well as reliable information on the collections of maize and wheat genetic resources it preserves; carrying out the activities required for seed introduction, processing, conservation, and distribution; complying with international agreements and standards; and hiring qualified staff to ensure that the requirements of our clients are met. The Bank is thus committed to complying with ISO 9001:2008 and continually improving the effectiveness of the Quality Management System. The Global Plan of Action (GPA) for plant genetic resources for food and agriculture aims to promote the conservation, sustainable utilization, and fair and equitable sharing of benefits of plant genetic resources. It is designed to contribute to the implementation of the Convention on Biological Diversity in the field of food and agriculture. The Plant Genetic Resource Center's specially designed vaults currently hold some 28,000 samples of maize and teosinte, a wild relative of maize, and 140,000 Triticeae samples, including bread wheat, durum wheat, and triticale (a man-made crop developed by crossing wheat with rye), with significant collections of barley, rye, and primitive and wild relatives of wheat. The Center also maintains a living collection of Tripsacum, a more distant maize relative.
ESBB conference Johannesburg, South Africa, Global Biobanking London, UK, HandsOn Biobanks 2016 conference Vienna, Austria, Managing Biomarker-Driven Clinical Trials Miami, USA, Genomic Sample Prep and Biomarker Assay Development San Francisco, USA, 2nd International Symposium on Germplasm of Ornamentals Atlanta, Georgia, IX International Symposium on In Vitro Culture and Horticultural Breeding Giza, Egypt, International Symposium on Role of Plant Genetic Resources on Reclaiming Lands and Environment Deteriorated by Human and Natural Actions Shiraz, Iran, VIII International Postharvest Symposium: Enhancing Supply Chain and Consumer Benefits - Ethical and Technological Issues Cartagena, Murcia, Spain.
According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver for biobanks, hospitals and gene banks, which are the major end-user segments of the biopreservation media & equipment market.
- Seed bank
- Spores and Mushroom Spores Bank
- Artificial seed production
- Plant Biobank
Related Conference of Germplasm Bank
14th International Conference on Human Genetics and Genetic Diseases
Germplasm Bank Conference Speakers
Recommended Sessions
- Biobanking Informatics
- Biorepository & Biospecimen
- Cryopreservation Methods
- Data Enrichment in Biobanks
- Ethical, legal and social issues in maintence of Biobanks
- Fertility biobanks
- Frontiers in Bioengineering and Biomaterials
- Germplasm Bank
- Next Generation Biobanking
- Quality Management Systems for Biobanking
- Stemcell Banking
- Tissue engineering
- Vitrification
Related Journals
Are you interested in
- 3D Bio-Printing and Organ Printing - Stemgen 2024 (UK)
- 3D bioprinting using Stem Cells - Stemgen 2024 (UK)
- Advanced Gene Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Advances in Cell Therapy Research - REGENERATIVE MED MEET 2024 (UK)
- Applications of Stem Cells - Stemgen 2024 (UK)
- Applications of Tissue engineering & Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Bio Banking - Stemgen 2024 (UK)
- Bio Banking Stem cell - Stem Cell 2024 (Ireland)
- Biochemical Genetics - Human Genetics 2024 (Canada)
- Bioengineering Therapeutics - WORLD CELL THERAPY 2024 (UK)
- Bioinformatics, Machine learning and Statistical methods - HUMAN GENETICS MEET 2024 (UAE)
- Biologic Scaffolds for Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Biomaterials & Bioengineering - REGENERATIVE MED MEET 2024 (UK)
- Bone Marrow Transplantation - Stem Cell 2024 (Ireland)
- Bone Marrow Transplantation - Stemgen 2024 (UK)
- Cancer Genetics - Human Genetics 2024 (Canada)
- Cancer Stem Cell and Oncology - Stemgen 2024 (UK)
- Cancer Therapies - WORLD CELL THERAPY 2024 (UK)
- Cancer, Cardiovascular Diseases and Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Cell and Gene Therapy - Stemgen 2024 (UK)
- Cell Culture and Bio processing - WORLD CELL THERAPY 2024 (UK)
- Cell Science and Stem Cell Research - WORLD CELL THERAPY 2024 (UK)
- Cell Therapy and Regenerative Medicine Market - REGENERATIVE MED MEET 2024 (UK)
- Cell Therapy in Pulmonology - WORLD CELL THERAPY 2024 (UK)
- Cellular Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Genetics - Human Genetics 2024 (Canada)
- Clinical Genetics and Novel Therapies of Genetic Diseases - HUMAN GENETICS MEET 2024 (UAE)
- Clinical Methods - Stem Cell 2024 (Ireland)
- Clinical Trials and Research in Cell and Gene Therapies - WORLD CELL THERAPY 2024 (UK)
- Clinical Trials on Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Cytogenetics - Human Genetics 2024 (Canada)
- Dental Stem Cell - Stemgen 2024 (UK)
- Dental Stem Cells - Stem Cell 2024 (Ireland)
- Developmental Genetics - Human Genetics 2024 (Canada)
- Diabetes Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Effect of Aging on Stem Cells - Stemgen 2024 (UK)
- Epigenetics - Human Genetics 2024 (Canada)
- Epigenetics and Gene Regulation - HUMAN GENETICS MEET 2024 (UAE)
- Ethical & Social Implications of Gene Editing - Human Genetics 2024 (Canada)
- Evolutionary and Population Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Functional Genomics and Transcriptomics - HUMAN GENETICS MEET 2024 (UAE)
- Gene Cloning and Mapping - HUMAN GENETICS MEET 2024 (UAE)
- Gene Therapy - Human Genetics 2024 (Canada)
- Gene Therapy - REGENERATIVE MED MEET 2024 (UK)
- Gene Therapy and Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Counseling - Human Genetics 2024 (Canada)
- Genetic Disorders - Human Genetics 2024 (Canada)
- Genetic Vaccines - WORLD CELL THERAPY 2024 (UK)
- Genomic Medicine & Molecular Diagnostics - Human Genetics 2024 (Canada)
- Genomics - Human Genetics 2024 (Canada)
- HIV Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Gene Therapy - WORLD CELL THERAPY 2024 (UK)
- Human Genetic Engineering - Human Genetics 2024 (Canada)
- Human genetics - Human Genetics 2024 (Canada)
- Human Genetics - HUMAN GENETICS MEET 2024 (UAE)
- Immunogenetics - Human Genetics 2024 (Canada)
- Immunotherapy - REGENERATIVE MED MEET 2024 (UK)
- Immunotherapy - WORLD CELL THERAPY 2024 (UK)
- Medical Genetics - Human Genetics 2024 (Canada)
- Models of Regeneration - REGENERATIVE MED MEET 2024 (UK)
- Molecular and Cytogenetics - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Effects of Genetic Variation - HUMAN GENETICS MEET 2024 (UAE)
- Molecular Epigenetics - WORLD CELL THERAPY 2024 (UK)
- Molecular Genetics - Human Genetics 2024 (Canada)
- Molecular Phenotyping and Omics Technologies - HUMAN GENETICS MEET 2024 (UAE)
- Mutation Detection and Analysis - HUMAN GENETICS MEET 2024 (UAE)
- Nano-Therapy - WORLD CELL THERAPY 2024 (UK)
- Nanotechnology in Cell Therapy and Regenerative Medicine - REGENERATIVE MED MEET 2024 (UK)
- Nanotechnology in Stem Cell - WORLD CELL THERAPY 2024 (UK)
- Neurodegenerative Disease - Stem Cell 2024 (Ireland)
- New Market Trends, R&D on Stem Cells - Stemgen 2024 (UK)
- Novel Approaches guided in Tissue Engineering - REGENERATIVE MED MEET 2024 (UK)
- Novel Stem Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Nutritional Genomics - Human Genetics 2024 (Canada)
- Oncogenomics and Cancer Heredity - Human Genetics 2024 (Canada)
- Orthopedics, Sports Medicine and Regenerative Rehabilitation - REGENERATIVE MED MEET 2024 (UK)
- Pharmacogenetics - Human Genetics 2024 (Canada)
- Pharmacogenomics - HUMAN GENETICS MEET 2024 (UAE)
- Population Genetics - Human Genetics 2024 (Canada)
- Regeneration and Therapeutics - Stem Cell 2024 (Ireland)
- Regenerative Medicine - Stemgen 2024 (UK)
- Regenerative Medicine in Aging, Dermatology and Plastic Surgery - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine Research - REGENERATIVE MED MEET 2024 (UK)
- Regenerative Medicine research and development - Stemgen 2024 (UK)
- Regenerative Therapy in Osteoarthritis - Stemgen 2024 (UK)
- Research and Development of Stem Cell & Regenerative Drugs - Stem Cell 2024 (Ireland)
- Sickle cell Anaemia Genomics - HUMAN GENETICS MEET 2024 (UAE)
- Skin Cell Therapy - WORLD CELL THERAPY 2024 (UK)
- Stem Cell and Tissue Engineering - Stemgen 2024 (UK)
- Stem Cell Animal Applications - Stem Cell 2024 (Ireland)
- Stem Cell Apoptosis and Signal Transmission - Stem Cell 2024 (Ireland)
- Stem Cell Embryology - Stem Cell 2024 (Ireland)
- Stem cell engineering - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Cardiovascular Disease - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Development - WORLD CELL THERAPY 2024 (UK)
- Stem Cell in Drug Discovery - Stem Cell 2024 (Ireland)
- Stem Cell Research - Human Genetics 2024 (Canada)
- Stem Cell Research and Therapy - Human Genetics 2024 (Canada)
- Stem Cell Therapies - WORLD CELL THERAPY 2024 (UK)
- Stem Cell Therapy - Stemgen 2024 (UK)
- Stem cell Transplantation - HUMAN GENETICS MEET 2024 (UAE)
- Stem Cell Transplantation - Stem Cell 2024 (Ireland)
- Stem Cell Transplantation to Avoid Cancer - Stemgen 2024 (UK)
- Stem Cells - Stem Cell 2024 (Ireland)
- Stem Cells and Disease Modelling - Stemgen 2024 (UK)
- The use of Stem Cells for COVID-19 Therapy - Stemgen 2024 (UK)
- Theories of Aging in Stem Biology - Stem Cell 2024 (Ireland)
- Tissue Engineering - Stem Cell 2024 (Ireland)
- Tissue Science and Engineering - REGENERATIVE MED MEET 2024 (UK)
- Translational Medicine - HUMAN GENETICS MEET 2024 (UAE)
- Translational Research in Stem Cell Assessments - Stem Cell 2024 (Ireland)
- Viral gene therapy - WORLD CELL THERAPY 2024 (UK)